These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 10910954

  • 21. [Effect of benzo[a]pyrene on DNA damage and expression of genes involved in nucleotide excision repair in lung cancer cells].
    Wu X, Zhou Y, Wang Z, Hao Q, Ren S.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Dec; 20(6):443-5. PubMed ID: 14694596
    [Abstract] [Full Text] [Related]

  • 22. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
    Sun XH, Hou WG, Zhao HX, Zhao YL, Ma C, Liu Y.
    Asian Pac J Cancer Prev; 2013 Dec; 14(3):2049-52. PubMed ID: 23679317
    [Abstract] [Full Text] [Related]

  • 23. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck.
    Ma H, Yu H, Liu Z, Wang LE, Sturgis EM, Wei Q.
    Pharmacogenet Genomics; 2012 Jan; 22(1):50-7. PubMed ID: 22108238
    [Abstract] [Full Text] [Related]

  • 24. Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck.
    Wei Q, Wang LE, Sturgis EM, Mao L.
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1961-6. PubMed ID: 16103444
    [Abstract] [Full Text] [Related]

  • 25. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
    Hu Z, Xu L, Shao M, Yuan J, Wang Y, Wang F, Yuan W, Qian J, Ma H, Wang Y, Liu H, Chen W, Yang L, Jing G, Huo X, Chen F, Jin L, Wei Q, Wu T, Lu D, Huang W, Shen H.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
    [Abstract] [Full Text] [Related]

  • 26. Reduced DNA repair capacity in lung cancer patients.
    Wei Q, Cheng L, Hong WK, Spitz MR.
    Cancer Res; 1996 Sep 15; 56(18):4103-7. PubMed ID: 8797573
    [Abstract] [Full Text] [Related]

  • 27. Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.
    Dabholkar MD, Berger MS, Vionnet JA, Overton L, Thompson C, Bostick-Bruton F, Yu JJ, Silber JR, Reed E.
    Mol Carcinog; 1996 Sep 15; 17(1):1-7. PubMed ID: 8876669
    [Abstract] [Full Text] [Related]

  • 28. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.
    Matakidou A, el Galta R, Webb EL, Rudd MF, Bridle H, GELCAPS Consortium, Eisen T, Houlston RS.
    Hum Mol Genet; 2007 Oct 01; 16(19):2333-40. PubMed ID: 17855454
    [Abstract] [Full Text] [Related]

  • 29. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
    Jeon HS, Kim KM, Park SH, Lee SY, Choi JE, Lee GY, Kam S, Park RW, Kim IS, Kim CH, Jung TH, Park JY.
    Carcinogenesis; 2003 Oct 01; 24(10):1677-81. PubMed ID: 12869423
    [Abstract] [Full Text] [Related]

  • 30. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Puente XS, Tardón A.
    BMC Cancer; 2007 Aug 16; 7():162. PubMed ID: 17705814
    [Abstract] [Full Text] [Related]

  • 31. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.
    Italiano A, Laurand A, Laroche A, Casali P, Sanfilippo R, Le Cesne A, Judson I, Blay JY, Ray-Coquard I, Bui B, Coindre JM, Nieto A, Tercero JC, Jimeno J, Robert J, Pourquier P.
    Cancer; 2011 Aug 01; 117(15):3445-56. PubMed ID: 21287534
    [Abstract] [Full Text] [Related]

  • 32. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.
    Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry CP, Seldin MF, Kelsey KT, Kittles RA, Silva G, Wiencke JK.
    Int J Cancer; 2008 Nov 01; 123(9):2095-104. PubMed ID: 18709642
    [Abstract] [Full Text] [Related]

  • 33. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q.
    Carcinogenesis; 2004 Sep 01; 25(9):1695-700. PubMed ID: 15090466
    [Abstract] [Full Text] [Related]

  • 34. DMBA-induced toxic and mutagenic responses vary dramatically between NER-deficient Xpa, Xpc and Csb mice.
    Wijnhoven SW, Kool HJ, Mullenders LH, Slater R, van Zeeland AA, Vrieling H.
    Carcinogenesis; 2001 Jul 01; 22(7):1099-106. PubMed ID: 11408355
    [Abstract] [Full Text] [Related]

  • 35. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes.
    Vogel U, Dybdahl M, Frentz G, Nexo BA.
    Mutat Res; 2000 Nov 09; 461(3):197-210. PubMed ID: 11056291
    [Abstract] [Full Text] [Related]

  • 36. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G, Imperatori L, Stefanini M, D'Incalci M.
    Int J Cancer; 1996 Jun 11; 66(6):779-83. PubMed ID: 8647649
    [Abstract] [Full Text] [Related]

  • 37. Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes.
    Tantin D, Kansal A, Carey M.
    Mol Cell Biol; 1997 Dec 11; 17(12):6803-14. PubMed ID: 9372911
    [Abstract] [Full Text] [Related]

  • 38. Nucleotide excision repair endonuclease genes in Drosophila melanogaster.
    Sekelsky JJ, Hollis KJ, Eimerl AI, Burtis KC, Hawley RS.
    Mutat Res; 2000 Apr 28; 459(3):219-28. PubMed ID: 10812334
    [Abstract] [Full Text] [Related]

  • 39. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.
    Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR.
    J Natl Cancer Inst; 2000 Nov 01; 92(21):1764-72. PubMed ID: 11058619
    [Abstract] [Full Text] [Related]

  • 40. Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response.
    Felip E, Rosell R.
    Expert Rev Mol Diagn; 2007 May 01; 7(3):261-8. PubMed ID: 17489733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.